The central question is whether WidePoint Corporation (WYY) can climb from roughly $9.45 to a $15 price target, a gain of about 59%. Bullish factors include a record contract backlog, a multi-billion-dollar federal contract pipeline, and a shift toward higher-margin recurring services.

WYY rose +6.56% to $10.07 during regular trading, up from a $9.45 prior-session close. No fresh company-specific headline drove the move; the gain extends a rebound following the roughly -19% selloff after Aug 14 Q2 results.

PLDT Inc. (PHI) is trading down roughly -7.5% near $17.91 after closing at $19.37 on Aug. 26. The slide began premarket with a gap-down open near $18.51 and extended during regular-session trading.

LUCK traded down -7.27% during the regular session to $6.25 versus the prior close of $6.74. The move followed fiscal Q4 earnings released premarket, when shares initially fell roughly -11%.

BHVN shares fell -5.96% during regular trading to $15.94, pulling back after Wednesday's roughly +18% surge to $16.95. The decline reflects profit-taking following the prior session's rally on the up to $795 million SK Biopharmaceuticals licensing deal for its Kv7 epilepsy platform.

AI-driven demand is outpacing supply: Management indicates laser chip and transceiver demand exceeds capacity, with several product lines effectively sold out into the foreseeable future. New architecture cycles are opening: Near-packaged optics (NPO), co-packaged optics (CPO), and optical circuit switches (OCS) represent multi-billion-dollar addressable-market expansions still in early revenue stages.

REAX is trading down about -10.7% intraday during regular market hours, at roughly $23.75 versus a $26.59 prior close. The drop extends a post-merger pullback: shares spiked +18.5% on Aug 25 when the Real–RE/MAX combination debuted under REAX, then fell -6.5% on Aug 26.

HRL slid -8.86% to about $21.61, extending a premarket drop into the regular session after fiscal Q3 earnings. Q3 net sales missed consensus at $2.96B (down -2.4% YoY) versus roughly $3.03B expected, though adjusted EPS of $0.37 edged past the $0.35 estimate.

SCTX fell -9.87% to roughly $28.57 intraday versus its prior close of $31.70, with the decline occurring during regular market hours. The move extends a post-IPO unwind: shares ran from the $15.00 July 24 IPO price to a $39.60 high on Aug 20 before momentum reversed, including a -16% drop on Aug 25.

NEXA dropped -10.33% to $13.97 during regular market hours, down from the prior session's close of $15.58. The selloff followed news that controlling shareholder Votorantim will give up control, selling its majority stake to Sweden's Boliden.

SIDU is trading up +3.56% during regular market hours, around $2.33 versus a prior close of $2.25. The move is driven by a broad space-sector rally, with peers Redwire (+14%), BlackSky (+13%) and AST SpaceMobile also surging in morning trading.

VEEV surged +19.63% to roughly $292.98 during regular trading, building on a strong post-earnings reaction. The rally followed fiscal Q2 results: revenue rose +17.6% year over year to $927.96 million, above the ~$905 million consensus.

CRWD is up +17.41% to $222.11 in regular trading on Aug 27, gapping higher after a strong fiscal Q2 report released after Tuesday's close. Revenue of $1.47B and adjusted EPS of $0.31 both beat consensus estimates of $1.44B and $0.29.

CRM jumped +18.82% to roughly $244, extending a post-earnings surge that began after-hours and accelerated in premarket trading following its fiscal Q2 2027 report. The primary catalyst was a blowout quarter: adjusted EPS of $5.90 versus $3.27 consensus (an +80% beat) and revenue of $11.35B, up +11% year-over-year.

NVDA is trading up +6.61% (to about $223.51) during Thursday's regular session, extending a sharp premarket surge of ~+7%. The move was driven by blowout Q2 FY2027 results reported Wednesday after the close: revenue of $96.2B (+106% YoY) beat the ~$92B consensus, with data-center revenue up +117%.

BBW tumbled -18.18%, falling from a prior close of $39.10 to about $31.99 in early regular-session trading after gapping down premarket. The drop followed fiscal Q2 2026 results: revenue of $115.3 million missed consensus (~$121–$122 million), down -7.2% year over year.

Everpure (P) is down -10.21% (-$11.12) to $97.78 during regular trading, reversing from Wednesday's $108.90 close. The drop unwinds an after-hours rally following its Q2 FY2027 earnings beat (EPS $0.70 vs $0.58; revenue +38% YoY) reported after Tuesday's close.

WEN fell -12.28% to about $7.93, extending a drop that began in Wednesday's after-hours session and continued through Thursday's premarket and regular trading. The primary catalyst: Reuters reported Nelson Peltz's Trian Fund Management has shelved its take-private bid for Wendy's, citing valuation, performance, and strategic concerns.

HQY is down -11.32% to $92.60 in regular trading, extending a roughly -7.6% premarket slide after results hit before the open. Catalyst: Q2 FY2027 earnings merely met elevated expectations — revenue +8% YoY to $350.7M and non-GAAP EPS $1.24 versus a $1.19 consensus.

BBY is trading down about -11.2% intraday near $77.60, after closing at $87.44 in the prior session. The decline occurred during regular market hours, extending a roughly -7% premarket slide following Q2 FY27 earnings.